Brian L. Strom | |
---|---|
1stChancellor of Rutgers Biomedical Health and Sciences | |
Assumed office December 2, 2013 | |
Preceded by | Office established |
Personal details | |
Born | December 8,1949 New York,New York |
Spouse | Elaine Strom |
Children | 2 |
Alma mater | Yale University (B.S.) The Johns Hopkins University School of Medicine (M.D.) University of California,Berkeley (M.P.H.) |
Website | http://rbhs.rutgers.edu/chancellor_info.shtml |
Brian L. Strom (born December 8,1949) is the inaugural Chancellor of Rutgers Biomedical and Health Sciences and the Executive Vice President for Health Affairs at Rutgers University. [1] Strom was the Executive Vice Dean for Institutional Affairs,Founding Chair of the Department of Biostatistics and Epidemiology,Founding Director of the Center for Clinical Epidemiology and Biostatistics,and Founding Director of the Graduate Program in Epidemiology and Biostatistics,at the Perelman School of Medicine of the University of Pennsylvania. In addition to writing more than 650 papers and 15 books,he has been principal investigator for more than 275 grants. He was honored as one of the Best Doctors in America for each of his last eight years at Penn.
Brian Leslie Strom was born on December 8,1949,in New York City. He grew up Floral Park,New York and attended Martin Van Buren High School in Queens Village. As an undergraduate,Strom attended Yale University,where he earned his Bachelor of Science degree in molecular biophysics and biochemistry. After graduating,he received his Doctor of Medicine at The Johns Hopkins University School of Medicine. Following his medical internship and residency in Internal Medicine at University of California,San Francisco,he earned a Master of Public Health degree in Epidemiology from the University of California,Berkeley while concurrently serving as an National Institutes of Health Research Fellow in Clinical Pharmacology at the University of California,San Francisco.
Strom is the Inaugural Chancellor of Rutgers Biomedical and Health Sciences (RBHS) and the Executive Vice President for Health Affairs at Rutgers University. [2] RBHS is composed of eight schools and seven major centers/institutes,and includes academic,patient care,and research facilities. These are most of the units of the former University of Medicine and Dentistry of New Jersey (UMDNJ),now dissolved,several Rutgers University units with health-related missions,and two research units historically co-managed by Rutgers and UMDNJ. The integration of these entities is designed to create a single organization that will lead to new models for clinical care and community service,educate the next generation of health care providers utilizing health care team approaches,and conduct research.
Strom has also done much work in clinical research training. At Penn,Strom developed graduate training programs in epidemiology and biostatistics. More than 625 clinicians trained through the largest of these programs,which leads to a Master of Science in Clinical Epidemiology. All but approximately 65 have appointments in academic or other research institutions. Strom was PI or Co-PI of 11 different NIH-funded training grants,each of which supported clinical epidemiology trainees in different specialties and subspecialties,and was the primary mentor for more than 40 clinical research trainees and numerous junior faculty members. Internationally,Dr. Strom was a key contributor to the conceptualization and planning that led to the development of the International Clinical Epidemiology Network (INCLEN),created in 1979 with support provided by the Rockefeller Foundation to provide clinical research training to clinicians from selected developing country sites. Penn was an INCLEN founding member and one of five training centers. INCLEN Phase I,from 1979 through 1995,resulted in the establishment of 26 clinical epidemiology units in Latin America,India,Africa,and Southeast Asia.
Strom's major research interest is in the field of pharmacoepidemiology,i.e.,the application of epidemiologic methods to the study of drug use and effects. He is recognized as a founder of this field and for his pioneer work in using large automated databases for research. He is editor of the field's major text (now in its fifth edition) and Editor-in-Chief for Pharmacoepidemiology and Drug Safety ,the official journal of the International Society for Pharmacoepidemiology. [3] As one of many specific contributions,his research was pivotal in prompting the American Heart Association and American Dental Association to reverse 50 years of guidelines,and recommend against use of antibiotics to prevent infective endocarditis,instead of recommending for this widespread practice. In addition to writing more than 650 papers and 15 books,he has been principal investigator for more than 275 grants,including over $115 million in direct costs alone. Strom has been invited to give more than 450 talks outside his local area,including presentations as the keynote speaker for numerous international meetings. He has been a consultant to NIH,FDA,CDC,USP,AAMC,JCAHO,foreign governments,most major pharmaceutical manufacturers,and many law firms.
The Council for International Organizations of Medical Sciences (CIOMS) is an international non-governmental organization of 40 international,national,and associate member groups representing the biomedical science community. It was jointly established by the World Health Organization (WHO) and United Nations Educational,Scientific and Cultural Organization (UNESCO) in 1949 as a successor to the International Medical Congress that organized 17 conferences from 1867 until the 1913 outbreak of World War One.
Joseph L. Fleiss was an American professor of biostatistics at the Columbia University Mailman School of Public Health,where he also served as head of the Division of Biostatistics from 1975 to 1992. He is known for his work in mental health statistics,particularly assessing the reliability of diagnostic classifications,and the measures,models,and control of errors in categorization.
Medical statistics deals with applications of statistics to medicine and the health sciences,including epidemiology,public health,forensic medicine,and clinical research. Medical statistics has been a recognized branch of statistics in the United Kingdom for more than 40 years but the term has not come into general use in North America,where the wider term 'biostatistics' is more commonly used. However,"biostatistics" more commonly connotes all applications of statistics to biology. Medical statistics is a subdiscipline of statistics. "It is the science of summarizing,collecting,presenting and interpreting data in medical practice,and using them to estimate the magnitude of associations and test hypotheses. It has a central role in medical investigations. It not only provides a way of organizing information on a wider and more formal basis than relying on the exchange of anecdotes and personal experience,but also takes into account the intrinsic variation inherent in most biological processes."
The International Society for Pharmacoepidemiology (ISPE) is a society focused on the practice of pharmacoepidemiology.
Pharmacoepidemiology is the study of the uses and effects of drugs in well-defined populations.
Perry N. Halkitis is an American of Greek ancestry public health psychologist and applied statistician known for his research on the health of LGBT populations with an emphasis on HIV/AIDS,substance use,and mental health. Perry is Dean and Professor of Biostatistics,Health Education,and Behavioral Science at the Rutgers School of Public Health.
Ruth Lillian Kirschstein was an American pathologist and science administrator at the National Institutes of Health (NIH). Kirschstein served as director of the National Institute of General Medical Sciences,deputy director of NIH in the 1990s,and acting director of the NIH in 1993 and 2000-2002.
Syed Ziaur Rahman is a permanent member of 'Board of Trustees' and Chair of the Advisory Council,International Association of Medical Colleges (IAOMC). He also serves as elected secretary of IAOMC and Society of Pharmacovigilance,India (SoPI).
Ian Ford [ FRSE FRCP(Glas) FSCT ] is a professor of biostatistics and a director of the Robertson Centre for Biostatistics,and a former Dean of Faculty of Information and Mathematical Sciences,at the University of Glasgow.
Dr. Moyses Szklo is a Brazilian epidemiologist and physician scientist. He is currently University Distinguished Service Professor of Epidemiology and Medicine at the Johns Hopkins University,Editor-in-chief Emeritus of the American Journal of Epidemiology,and director of the Johns Hopkins Summer Institute of Epidemiology and Biostatistics. Szklo has published over 300 articles in peer-reviewed journals as well as a major textbook of epidemiology. He has led several major epidemiologic societies and studies and has been lecturing and leading courses all over the world,including Spain,Italy,Israel,Brazil,and Mexico.
Paul Kieran Whelton is an Irish-born American physician and scientist who has contributed to the fields of hypertension and kidney disease epidemiology. He also mentored several public health leaders including the deans of the schools of public health at Johns Hopkins and Columbia. He currently serves as the Show Chwan Health Care System Endowed Chair in Global Public Health and a Clinical Professor in the Department of Epidemiology at the Tulane University School of Public Health and Tropical Medicine. He is the founding director of the Welch Center for Prevention,Epidemiology,and Clinical Research at Johns Hopkins University.
Kameshwar Prasad is an Indian neurologist,medical researcher,academic and the head of the Department of Neurology at the All India Institute of Medical Sciences,Delhi (AIIMS),known as a proponent of evidence-based medicine (EBM) and evidence-based healthcare (EBHC). The government of India awarded him the fourth highest civilian honour of the Padma Shri in 1991.
Hans-Olov Adami is a Swedish physician,academic and public health researcher. He established the largest epidemiologic and biostatistics research unit in Sweden,the Department of Medical Epidemiology and Biostatistics at the Karolinska Institutet. He is a former chair of the Department of Epidemiology at the Harvard School of Public Health in Boston,US.
Miguel Hernán is a Spanish-American epidemiologist. He is the Director of the CAUSALab,Kolokotrones Professor of Biostatistics and Epidemiology at the Harvard T.H. Chan School of Public Health,and Member of the Faculty at the Harvard–MIT Program in Health Sciences and Technology.
Susan S. Ellenberg is an American statistician specializing in the design of clinical trials and in the safety of medical products. She is a professor of biostatistics,medical ethics and health policy in the Perelman School of Medicine at the University of Pennsylvania. She was the 1993 president of the Society for Clinical Trials and the 1999 President of the Eastern North American Region of the International Biometric Society.
Cheryl Ann Marie Anderson is an American epidemiologist. Anderson is a professor at and founding Dean of the University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science. Anderson's research focus is on nutrition and chronic disease prevention in under-served human populations.
Joerg Hasford is a German physician,biometrician,and epidemiologist. He is emeritus professor in the Institute for Medical Informatics,Biometry and Epidemiology at Ludwig Maximilian University of Munich,chair of the Ethics Committee of the Physicians’Chamber of the Free State of Bavaria,president of the Association of the Research Ethics Committees in Germany and a member of the Expert Group on Clinical Trials of the European Commission. He has been influential in the study of safety of drugs and pharmacoepidemiology. He was one of the first biostatisticians to look at reliably compiled drug dosing history data in light of pharmacometric consequences. He is the namesake of the Hasford Score,a prognostic score for chronic myeloid leukemia.
Ronald S. Brookmeyer is an American public health researcher. He is a professor of biostatistics at the UCLA Fielding School of Public Health.
J. Richard Landis is an American biostatistician and Emeritus Professor of Biostatistics in the Perelman School of Medicine at the University of Pennsylvania,where he is also the senior vice chair of the Department of Biostatistics,Epidemiology and Informatics,director of the Biostatistics Unit within the Center for Clinical Epidemiology and Biostatistics,and faculty Director of the Clinical Research Computing Unit.
Mitchell H. Gail is an American physician-scientist and biostatistician. He is a distinguished investigator at the National Cancer Institute.